| Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition L Xing, Z Dai, A Jabbari, JE Cerise, CA Higgins, W Gong, A De Jong, ... Nature medicine 20 (9), 1043-1049, 2014 | 976 | 2014 |
| Accelerated CD8+ T-cell memory and prime-boost response after dendritic-cell vaccination VP Badovinac, KAN Messingham, A Jabbari, JS Haring, JT Harty Nature medicine 11 (7), 748-756, 2005 | 547 | 2005 |
| Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata MK Crispin, JM Ko, BG Craiglow, S Li, G Shankar, JR Urban, JC Chen, ... JCI insight 1 (15), 2016 | 373 | 2016 |
| Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata J Mackay-Wiggan, A Jabbari, N Nguyen, JE Cerise, C Clark, G Ulerio, ... JCI insight 1 (15), 2016 | 292 | 2016 |
| Reversal of alopecia areata following treatment with the JAK1/2 inhibitor baricitinib A Jabbari, Z Dai, L Xing, JE Cerise, Y Ramot, Y Berkun, GAM Sanchez, ... EBioMedicine 2 (4), 351-355, 2015 | 275 | 2015 |
| Rapid skin repigmentation on oral ruxolitinib in a patient with coexistent vitiligo and alopecia areata (AA) JE Harris, M Rashighi, N Nguyen, A Jabbari, G Ulerio, R Clynes, ... Journal of the American Academy of Dermatology 74 (2), 370-371, 2016 | 225 | 2016 |
| Secondary memory CD8+ T cells are more protective but slower to acquire a central–memory phenotype A Jabbari, JT Harty The Journal of experimental medicine 203 (4), 919-932, 2006 | 220 | 2006 |
| Meta-analysis derived (MAD) transcriptome of psoriasis defines the “core” pathogenesis of disease S Tian, JG Krueger, K Li, A Jabbari, C Brodmerkel, MA Lowes, ... Public Library of Science 7 (9), e44274, 2012 | 207 | 2012 |
| An open-label pilot study to evaluate the efficacy of tofacitinib in moderate to severe patch-type alopecia areata, totalis, and universalis A Jabbari, F Sansaricq, J Cerise, JC Chen, A Bitterman, G Ulerio, ... Journal of Investigative Dermatology 138 (7), 1539-1545, 2018 | 193 | 2018 |
| Dominant Th1 and minimal Th17 skewing in discoid lupus revealed by transcriptomic comparison with psoriasis A Jabbari, M Suárez-Fariñas, J Fuentes-Duculan, J Gonzalez, I Cueto, ... Journal of Investigative Dermatology 134 (1), 87-95, 2014 | 121 | 2014 |
| Transcriptional profiling of psoriasis using RNA-seq reveals previously unidentified differentially expressed genes A Jabbari, M Suárez-Fariñas, S Dewell, JG Krueger The Journal of investigative dermatology 132 (1), 246, 2011 | 110 | 2011 |
| Molecular signatures define alopecia areata subtypes and transcriptional biomarkers A Jabbari, JE Cerise, JC Chen, J Mackay-Wiggan, M Duvic, V Price, ... EBioMedicine 7, 240-247, 2016 | 107 | 2016 |
| Single-cell profiling of cutaneous T-cell lymphoma reveals underlying heterogeneity associated with disease progression N Borcherding, AP Voigt, V Liu, BK Link, W Zhang, A Jabbari Clinical Cancer Research 25 (10), 2996-3005, 2019 | 104 | 2019 |
| Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers A Jabbari, N Nguyen, JE Cerise, G Ulerio, A de Jong, R Clynes, ... Experimental dermatology 25 (8), 642, 2016 | 98 | 2016 |
| An overview of JAK/STAT pathways and JAK inhibition in alopecia areata M Lensing, A Jabbari Frontiers in immunology 13, 955035, 2022 | 90 | 2022 |
| Genetic basis of alopecia areata: a roadmap for translational research A Jabbari, L Petukhova, RM Cabral, R Clynes, AM Christiano Dermatologic clinics 31 (1), 109-117, 2013 | 85 | 2013 |
| CXCR3 blockade inhibits T cell migration into the skin and prevents development of alopecia areata Z Dai, L Xing, J Cerise, EHC Wang, A Jabbari, A de Jong, L Petukhova, ... The Journal of Immunology 197 (4), 1089-1099, 2016 | 83 | 2016 |
| High-throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in alopecia areata A de Jong, A Jabbari, Z Dai, L Xing, D Lee, MM Li, M Duvic, M Hordinsky, ... JCI insight 3 (19), 2018 | 58 | 2018 |
| A role for IFN-γ from antigen-specific CD8+ T cells in protective immunity to Listeria monocytogenes KAN Messingham, VP Badovinac, A Jabbari, JT Harty The Journal of Immunology 179 (4), 2457-2466, 2007 | 51 | 2007 |
| Ruxolitinib attenuates cutaneous lupus development in a mouse lupus model ES Chan, LC Herlitz, J Ali The Journal of investigative dermatology 135 (9), 2338-2339, 2015 | 46 | 2015 |
